nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciprofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.506	1	CbGaD
Ciprofloxacin—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.052	0.209	CbGbCtD
Ciprofloxacin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0423	0.17	CbGbCtD
Ciprofloxacin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0286	0.115	CbGbCtD
Ciprofloxacin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0272	0.11	CbGbCtD
Ciprofloxacin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0243	0.0978	CbGbCtD
Ciprofloxacin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0238	0.0958	CbGbCtD
Ciprofloxacin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0225	0.0904	CbGbCtD
Ciprofloxacin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0142	0.0574	CbGbCtD
Ciprofloxacin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0135	0.0542	CbGbCtD
Ciprofloxacin—TOP2A—Salmeterol—Salbutamol—chronic obstructive pulmonary disease	0.00224	0.807	CbGdCrCtD
Ciprofloxacin—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00128	0.0577	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00112	0.0503	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000987	0.0445	CbGpPWpGaD
Ciprofloxacin—Pefloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000907	0.178	CrCbGaD
Ciprofloxacin—Enoxacin—CYP1A2—chronic obstructive pulmonary disease	0.000849	0.166	CrCbGaD
Ciprofloxacin—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000807	0.0364	CbGpPWpGaD
Ciprofloxacin—Gatifloxacin—ALB—chronic obstructive pulmonary disease	0.000691	0.136	CrCbGaD
Ciprofloxacin—Lomefloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000643	0.126	CrCbGaD
Ciprofloxacin—Ofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.00055	0.108	CrCbGaD
Ciprofloxacin—Levofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.00055	0.108	CrCbGaD
Ciprofloxacin—CYP3A7—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000527	0.0237	CbGpPWpGaD
Ciprofloxacin—Norfloxacin—CYP1A1—chronic obstructive pulmonary disease	0.000462	0.0907	CrCbGaD
Ciprofloxacin—Norfloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000446	0.0874	CrCbGaD
Ciprofloxacin—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00041	0.0185	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000407	0.0183	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000397	0.0179	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000383	0.0172	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000381	0.0172	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000366	0.0165	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000347	0.0156	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000325	0.0146	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000316	0.0142	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000314	0.0142	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000277	0.0125	CbGpPWpGaD
Ciprofloxacin—TOP2A—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.000271	0.0975	CbGdCrCtD
Ciprofloxacin—CYP3A5—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000266	0.012	CbGpPWpGaD
Ciprofloxacin—TOP2A—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.0952	CbGdCrCtD
Ciprofloxacin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000244	0.011	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000235	0.0106	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000224	0.0101	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000219	0.00986	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000216	0.00973	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000212	0.00954	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000199	0.00898	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000193	0.00868	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000191	0.00862	CbGpPWpGaD
Ciprofloxacin—TOP2A—Gastric Cancer Network 2—EGFR—chronic obstructive pulmonary disease	0.000188	0.00848	CbGpPWpGaD
Ciprofloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000188	0.00847	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000184	0.00831	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000181	0.00817	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.00799	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.00798	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00017	0.00767	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000167	0.00751	CbGpPWpGaD
Ciprofloxacin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.000757	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000163	0.000755	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000163	0.000754	CcSEcCtD
Ciprofloxacin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.000754	CcSEcCtD
Ciprofloxacin—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000753	CcSEcCtD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000162	0.00729	CbGpPWpGaD
Ciprofloxacin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000161	0.000748	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000742	CcSEcCtD
Ciprofloxacin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000742	CcSEcCtD
Ciprofloxacin—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00722	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.00716	CbGpPWpGaD
Ciprofloxacin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000159	0.000735	CcSEcCtD
Ciprofloxacin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.000735	CcSEcCtD
Ciprofloxacin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.000734	CcSEcCtD
Ciprofloxacin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000158	0.00713	CbGpPWpGaD
Ciprofloxacin—TOP2A—Gastric Cancer Network 2—TP53—chronic obstructive pulmonary disease	0.000158	0.00712	CbGpPWpGaD
Ciprofloxacin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000158	0.000731	CcSEcCtD
Ciprofloxacin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00073	CcSEcCtD
Ciprofloxacin—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.000729	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.000728	CcSEcCtD
Ciprofloxacin—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000727	CcSEcCtD
Ciprofloxacin—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.00707	CbGpPWpGaD
Ciprofloxacin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.000724	CcSEcCtD
Ciprofloxacin—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000156	0.00703	CbGpPWpGaD
Ciprofloxacin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.000721	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.000718	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.000718	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.000716	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000155	0.000716	CcSEcCtD
Ciprofloxacin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000154	0.00693	CbGpPWpGaD
Ciprofloxacin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000154	0.000711	CcSEcCtD
Ciprofloxacin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.000711	CcSEcCtD
Ciprofloxacin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000708	CcSEcCtD
Ciprofloxacin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000153	0.000707	CcSEcCtD
Ciprofloxacin—TOP2A—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000152	0.00686	CbGpPWpGaD
Ciprofloxacin—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000704	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000151	0.000702	CcSEcCtD
Ciprofloxacin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000151	0.000701	CcSEcCtD
Ciprofloxacin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.000701	CcSEcCtD
Ciprofloxacin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000151	0.000699	CcSEcCtD
Ciprofloxacin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.000699	CcSEcCtD
Ciprofloxacin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00015	0.000696	CcSEcCtD
Ciprofloxacin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000694	CcSEcCtD
Ciprofloxacin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.000692	CcSEcCtD
Ciprofloxacin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000149	0.000692	CcSEcCtD
Ciprofloxacin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000149	0.000691	CcSEcCtD
Ciprofloxacin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000149	0.000689	CcSEcCtD
Ciprofloxacin—Injury—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000685	CcSEcCtD
Ciprofloxacin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000148	0.000685	CcSEcCtD
Ciprofloxacin—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000148	0.00665	CbGpPWpGaD
Ciprofloxacin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.000683	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.000679	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000147	0.000679	CcSEcCtD
Ciprofloxacin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000146	0.000678	CcSEcCtD
Ciprofloxacin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.000678	CcSEcCtD
Ciprofloxacin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000146	0.000678	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000676	CcSEcCtD
Ciprofloxacin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.000672	CcSEcCtD
Ciprofloxacin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.000672	CcSEcCtD
Ciprofloxacin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000145	0.000672	CcSEcCtD
Ciprofloxacin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000145	0.000672	CcSEcCtD
Ciprofloxacin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.000671	CcSEcCtD
Ciprofloxacin—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00067	CcSEcCtD
Ciprofloxacin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.000667	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000144	0.000665	CcSEcCtD
Ciprofloxacin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000143	0.000664	CcSEcCtD
Ciprofloxacin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.000662	CcSEcCtD
Ciprofloxacin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.00066	CcSEcCtD
Ciprofloxacin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000142	0.000658	CcSEcCtD
Ciprofloxacin—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000658	CcSEcCtD
Ciprofloxacin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000142	0.000657	CcSEcCtD
Ciprofloxacin—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000654	CcSEcCtD
Ciprofloxacin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000654	CcSEcCtD
Ciprofloxacin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000653	CcSEcCtD
Ciprofloxacin—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000653	CcSEcCtD
Ciprofloxacin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000141	0.000651	CcSEcCtD
Ciprofloxacin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00014	0.000651	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.00014	0.00631	CbGpPWpGaD
Ciprofloxacin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.000649	CcSEcCtD
Ciprofloxacin—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00014	0.00631	CbGpPWpGaD
Ciprofloxacin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00014	0.000648	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.000648	CcSEcCtD
Ciprofloxacin—TOP2A—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.00014	0.0063	CbGpPWpGaD
Ciprofloxacin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00014	0.000647	CcSEcCtD
Ciprofloxacin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000645	CcSEcCtD
Ciprofloxacin—TOP2A—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000139	0.00628	CbGpPWpGaD
Ciprofloxacin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.000644	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.000643	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000139	0.000643	CcSEcCtD
Ciprofloxacin—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000642	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000641	CcSEcCtD
Ciprofloxacin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00064	CcSEcCtD
Ciprofloxacin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.000635	CcSEcCtD
Ciprofloxacin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.000635	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00063	CcSEcCtD
Ciprofloxacin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000629	CcSEcCtD
Ciprofloxacin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.000625	CcSEcCtD
Ciprofloxacin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000135	0.000625	CcSEcCtD
Ciprofloxacin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000621	CcSEcCtD
Ciprofloxacin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000621	CcSEcCtD
Ciprofloxacin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000621	CcSEcCtD
Ciprofloxacin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000621	CcSEcCtD
Ciprofloxacin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000134	0.000619	CcSEcCtD
Ciprofloxacin—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000615	CcSEcCtD
Ciprofloxacin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000133	0.000614	CcSEcCtD
Ciprofloxacin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000132	0.000614	CcSEcCtD
Ciprofloxacin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000132	0.000614	CcSEcCtD
Ciprofloxacin—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000132	0.00595	CbGpPWpGaD
Ciprofloxacin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000132	0.000612	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000612	CcSEcCtD
Ciprofloxacin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000132	0.00061	CcSEcCtD
Ciprofloxacin—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.00061	CcSEcCtD
Ciprofloxacin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000609	CcSEcCtD
Ciprofloxacin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000609	CcSEcCtD
Ciprofloxacin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000608	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.000607	CcSEcCtD
Ciprofloxacin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.000602	CcSEcCtD
Ciprofloxacin—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000601	CcSEcCtD
Ciprofloxacin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.000599	CcSEcCtD
Ciprofloxacin—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000599	CcSEcCtD
Ciprofloxacin—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.00581	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.0058	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.00578	CbGpPWpGaD
Ciprofloxacin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00059	CcSEcCtD
Ciprofloxacin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000587	CcSEcCtD
Ciprofloxacin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000587	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.000579	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000125	0.000579	CcSEcCtD
Ciprofloxacin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000125	0.000579	CcSEcCtD
Ciprofloxacin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.000578	CcSEcCtD
Ciprofloxacin—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000577	CcSEcCtD
Ciprofloxacin—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.00558	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.00557	CbGpPWpGaD
Ciprofloxacin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000122	0.000567	CcSEcCtD
Ciprofloxacin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000564	CcSEcCtD
Ciprofloxacin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000564	CcSEcCtD
Ciprofloxacin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00012	0.000556	CcSEcCtD
Ciprofloxacin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.000556	CcSEcCtD
Ciprofloxacin—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000555	CcSEcCtD
Ciprofloxacin—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000555	CcSEcCtD
Ciprofloxacin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000119	0.000552	CcSEcCtD
Ciprofloxacin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000548	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000547	CcSEcCtD
Ciprofloxacin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000118	0.000545	CcSEcCtD
Ciprofloxacin—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000117	0.00529	CbGpPWpGaD
Ciprofloxacin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000116	0.000538	CcSEcCtD
Ciprofloxacin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.000538	CcSEcCtD
Ciprofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000116	0.00522	CbGpPWpGaD
Ciprofloxacin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000535	CcSEcCtD
Ciprofloxacin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000533	CcSEcCtD
Ciprofloxacin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000533	CcSEcCtD
Ciprofloxacin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.00518	CbGpPWpGaD
Ciprofloxacin—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00053	CcSEcCtD
Ciprofloxacin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000527	CcSEcCtD
Ciprofloxacin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000525	CcSEcCtD
Ciprofloxacin—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.00511	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000113	0.00511	CbGpPWpGaD
Ciprofloxacin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000522	CcSEcCtD
Ciprofloxacin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000112	0.00052	CcSEcCtD
Ciprofloxacin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.00052	CcSEcCtD
Ciprofloxacin—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000112	0.00505	CbGpPWpGaD
Ciprofloxacin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000509	CcSEcCtD
Ciprofloxacin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000509	CcSEcCtD
Ciprofloxacin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000508	CcSEcCtD
Ciprofloxacin—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000108	0.00487	CbGpPWpGaD
Ciprofloxacin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000108	0.0005	CcSEcCtD
Ciprofloxacin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.0005	CcSEcCtD
Ciprofloxacin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000496	CcSEcCtD
Ciprofloxacin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000496	CcSEcCtD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000107	0.00482	CbGpPWpGaD
Ciprofloxacin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000495	CcSEcCtD
Ciprofloxacin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000495	CcSEcCtD
Ciprofloxacin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000106	0.000493	CcSEcCtD
Ciprofloxacin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.000493	CcSEcCtD
Ciprofloxacin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000492	CcSEcCtD
Ciprofloxacin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000491	CcSEcCtD
Ciprofloxacin—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000491	CcSEcCtD
Ciprofloxacin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000106	0.00049	CcSEcCtD
Ciprofloxacin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000486	CcSEcCtD
Ciprofloxacin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000485	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000484	CcSEcCtD
Ciprofloxacin—Depression—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000484	CcSEcCtD
Ciprofloxacin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000104	0.000482	CcSEcCtD
Ciprofloxacin—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000478	CcSEcCtD
Ciprofloxacin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000477	CcSEcCtD
Ciprofloxacin—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000476	CcSEcCtD
Ciprofloxacin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000476	CcSEcCtD
Ciprofloxacin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000472	CcSEcCtD
Ciprofloxacin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.00047	CcSEcCtD
Ciprofloxacin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000469	CcSEcCtD
Ciprofloxacin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000468	CcSEcCtD
Ciprofloxacin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000468	CcSEcCtD
Ciprofloxacin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000468	CcSEcCtD
Ciprofloxacin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000467	CcSEcCtD
Ciprofloxacin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000467	CcSEcCtD
Ciprofloxacin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.000465	CcSEcCtD
Ciprofloxacin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	9.9e-05	0.000459	CcSEcCtD
Ciprofloxacin—Nausea—Montelukast—chronic obstructive pulmonary disease	9.87e-05	0.000457	CcSEcCtD
Ciprofloxacin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	9.76e-05	0.000452	CcSEcCtD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.74e-05	0.00439	CbGpPWpGaD
Ciprofloxacin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	9.72e-05	0.00045	CcSEcCtD
Ciprofloxacin—Bradycardia—Prednisone—chronic obstructive pulmonary disease	9.57e-05	0.000443	CcSEcCtD
Ciprofloxacin—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.52e-05	0.000441	CcSEcCtD
Ciprofloxacin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	9.47e-05	0.000439	CcSEcCtD
Ciprofloxacin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	9.45e-05	0.000438	CcSEcCtD
Ciprofloxacin—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.42e-05	0.00424	CbGpPWpGaD
Ciprofloxacin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.4e-05	0.000435	CcSEcCtD
Ciprofloxacin—Hallucination—Prednisone—chronic obstructive pulmonary disease	9.35e-05	0.000433	CcSEcCtD
Ciprofloxacin—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.31e-05	0.0042	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.29e-05	0.00419	CbGpPWpGaD
Ciprofloxacin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	9.24e-05	0.000428	CcSEcCtD
Ciprofloxacin—Oedema—Prednisolone—chronic obstructive pulmonary disease	9.19e-05	0.000426	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	9.19e-05	0.000426	CcSEcCtD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	9.09e-05	0.0041	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	9.09e-05	0.0041	CbGpPWpGaD
Ciprofloxacin—Shock—Prednisolone—chronic obstructive pulmonary disease	9.04e-05	0.000419	CcSEcCtD
Ciprofloxacin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.97e-05	0.000416	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.89e-05	0.000412	CcSEcCtD
Ciprofloxacin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	8.79e-05	0.000407	CcSEcCtD
Ciprofloxacin—Flushing—Prednisone—chronic obstructive pulmonary disease	8.73e-05	0.000404	CcSEcCtD
Ciprofloxacin—TOP2A—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	8.68e-05	0.00391	CbGpPWpGaD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	8.57e-05	0.00386	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	8.56e-05	0.00386	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.56e-05	0.00386	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	8.56e-05	0.00386	CbGpPWpGaD
Ciprofloxacin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	8.53e-05	0.000395	CcSEcCtD
Ciprofloxacin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000393	CcSEcCtD
Ciprofloxacin—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	8.43e-05	0.0038	CbGpPWpGaD
Ciprofloxacin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	8.4e-05	0.000389	CcSEcCtD
Ciprofloxacin—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	8.34e-05	0.00376	CbGpPWpGaD
Ciprofloxacin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	8.31e-05	0.000385	CcSEcCtD
Ciprofloxacin—Alopecia—Prednisone—chronic obstructive pulmonary disease	8.31e-05	0.000385	CcSEcCtD
Ciprofloxacin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	8.25e-05	0.000382	CcSEcCtD
Ciprofloxacin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	8.24e-05	0.000382	CcSEcCtD
Ciprofloxacin—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.19e-05	0.00369	CbGpPWpGaD
Ciprofloxacin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	8.18e-05	0.000379	CcSEcCtD
Ciprofloxacin—Erythema—Prednisone—chronic obstructive pulmonary disease	8.18e-05	0.000379	CcSEcCtD
Ciprofloxacin—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.1e-05	0.00365	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	8.09e-05	0.00365	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.01e-05	0.00361	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	7.86e-05	0.00354	CbGpPWpGaD
Ciprofloxacin—Pain—Prednisolone—chronic obstructive pulmonary disease	7.86e-05	0.000364	CcSEcCtD
Ciprofloxacin—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.85e-05	0.00354	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.75e-05	0.00349	CbGpPWpGaD
Ciprofloxacin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.000357	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.000352	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.57e-05	0.000351	CcSEcCtD
Ciprofloxacin—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.56e-05	0.00035	CcSEcCtD
Ciprofloxacin—Agitation—Prednisone—chronic obstructive pulmonary disease	7.52e-05	0.000348	CcSEcCtD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.52e-05	0.00339	CbGpPWpGaD
Ciprofloxacin—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.48e-05	0.000346	CcSEcCtD
Ciprofloxacin—Malaise—Prednisone—chronic obstructive pulmonary disease	7.38e-05	0.000342	CcSEcCtD
Ciprofloxacin—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.000341	CcSEcCtD
Ciprofloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.35e-05	0.00331	CbGpPWpGaD
Ciprofloxacin—Syncope—Prednisone—chronic obstructive pulmonary disease	7.34e-05	0.00034	CcSEcCtD
Ciprofloxacin—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	7.34e-05	0.00331	CbGpPWpGaD
Ciprofloxacin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.3e-05	0.000338	CcSEcCtD
Ciprofloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.25e-05	0.00327	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.22e-05	0.00325	CbGpPWpGaD
Ciprofloxacin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.19e-05	0.000333	CcSEcCtD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.12e-05	0.00321	CbGpPWpGaD
Ciprofloxacin—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.09e-05	0.000328	CcSEcCtD
Ciprofloxacin—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.07e-05	0.000327	CcSEcCtD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	7.01e-05	0.00316	CbGpPWpGaD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	6.97e-05	0.00314	CbGpPWpGaD
Ciprofloxacin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.97e-05	0.000323	CcSEcCtD
Ciprofloxacin—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.97e-05	0.000323	CcSEcCtD
Ciprofloxacin—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.94e-05	0.000322	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	6.92e-05	0.00312	CbGpPWpGaD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	6.92e-05	0.000321	CcSEcCtD
Ciprofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.92e-05	0.00312	CbGpPWpGaD
Ciprofloxacin—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.88e-05	0.000319	CcSEcCtD
Ciprofloxacin—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.84e-05	0.00308	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.83e-05	0.00308	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	6.81e-05	0.00307	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.81e-05	0.00307	CbGpPWpGaD
Ciprofloxacin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.77e-05	0.000314	CcSEcCtD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.75e-05	0.00304	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.71e-05	0.00303	CbGpPWpGaD
Ciprofloxacin—Oedema—Prednisone—chronic obstructive pulmonary disease	6.68e-05	0.000309	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.68e-05	0.000309	CcSEcCtD
Ciprofloxacin—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.6e-05	0.00298	CbGpPWpGaD
Ciprofloxacin—Shock—Prednisone—chronic obstructive pulmonary disease	6.57e-05	0.000304	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.55e-05	0.000303	CcSEcCtD
Ciprofloxacin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.52e-05	0.000302	CcSEcCtD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	6.5e-05	0.00293	CbGpPWpGaD
Ciprofloxacin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.49e-05	0.000301	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.46e-05	0.000299	CcSEcCtD
Ciprofloxacin—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.000295	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.09e-05	0.000282	CcSEcCtD
Ciprofloxacin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.08e-05	0.000282	CcSEcCtD
Ciprofloxacin—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.04e-05	0.00028	CcSEcCtD
Ciprofloxacin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6e-05	0.000278	CcSEcCtD
Ciprofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.96e-05	0.00269	CbGpPWpGaD
Ciprofloxacin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000272	CcSEcCtD
Ciprofloxacin—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	5.85e-05	0.00264	CbGpPWpGaD
Ciprofloxacin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000269	CcSEcCtD
Ciprofloxacin—Rash—Prednisolone—chronic obstructive pulmonary disease	5.8e-05	0.000268	CcSEcCtD
Ciprofloxacin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.79e-05	0.000268	CcSEcCtD
Ciprofloxacin—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.000267	CcSEcCtD
Ciprofloxacin—Headache—Prednisolone—chronic obstructive pulmonary disease	5.76e-05	0.000267	CcSEcCtD
Ciprofloxacin—Constipation—Prednisone—chronic obstructive pulmonary disease	5.71e-05	0.000265	CcSEcCtD
Ciprofloxacin—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.68e-05	0.00256	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.61e-05	0.00253	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.6e-05	0.00252	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	5.5e-05	0.00248	CbGpPWpGaD
Ciprofloxacin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.000255	CcSEcCtD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	5.47e-05	0.00247	CbGpPWpGaD
Ciprofloxacin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.46e-05	0.000253	CcSEcCtD
Ciprofloxacin—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.46e-05	0.000253	CcSEcCtD
Ciprofloxacin—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.37e-05	0.00242	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.34e-05	0.00241	CbGpPWpGaD
Ciprofloxacin—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.31e-05	0.000246	CcSEcCtD
Ciprofloxacin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.000245	CcSEcCtD
Ciprofloxacin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.000245	CcSEcCtD
Ciprofloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.27e-05	0.00238	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.22e-05	0.00235	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.15e-05	0.00232	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.95e-05	0.00223	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.93e-05	0.00222	CbGpPWpGaD
Ciprofloxacin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000228	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.88e-05	0.0022	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.88e-05	0.0022	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.88e-05	0.0022	CbGpPWpGaD
Ciprofloxacin—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.79e-05	0.000222	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.73e-05	0.00213	CbGpPWpGaD
Ciprofloxacin—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.73e-05	0.000219	CcSEcCtD
Ciprofloxacin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.57e-05	0.000212	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.48e-05	0.00202	CbGpPWpGaD
Ciprofloxacin—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.42e-05	0.000205	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.39e-05	0.00198	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.33e-05	0.00195	CbGpPWpGaD
Ciprofloxacin—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.25e-05	0.000197	CcSEcCtD
Ciprofloxacin—Rash—Prednisone—chronic obstructive pulmonary disease	4.21e-05	0.000195	CcSEcCtD
Ciprofloxacin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.21e-05	0.000195	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.18e-05	0.00189	CbGpPWpGaD
Ciprofloxacin—Headache—Prednisone—chronic obstructive pulmonary disease	4.18e-05	0.000194	CcSEcCtD
Ciprofloxacin—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	4.01e-05	0.00181	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.01e-05	0.00181	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	3.98e-05	0.00179	CbGpPWpGaD
Ciprofloxacin—Nausea—Prednisone—chronic obstructive pulmonary disease	3.97e-05	0.000184	CcSEcCtD
Ciprofloxacin—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	3.85e-05	0.00173	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.81e-05	0.00172	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.76e-05	0.0017	CbGpPWpGaD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	3.76e-05	0.0017	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.69e-05	0.00166	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.68e-05	0.00166	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.65e-05	0.00164	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.61e-05	0.00163	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.61e-05	0.00163	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	3.55e-05	0.0016	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.54e-05	0.0016	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.47e-05	0.00156	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.44e-05	0.00155	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.44e-05	0.00155	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.42e-05	0.00154	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.37e-05	0.00152	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.3e-05	0.00149	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.26e-05	0.00147	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.24e-05	0.00146	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.16e-05	0.00143	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.14e-05	0.00142	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.12e-05	0.00141	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.1e-05	0.0014	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3e-05	0.00135	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	2.99e-05	0.00135	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.98e-05	0.00134	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.94e-05	0.00132	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.79e-05	0.00126	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.64e-05	0.00119	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.64e-05	0.00119	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.6e-05	0.00117	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.56e-05	0.00116	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.43e-05	0.00109	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.4e-05	0.00108	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.39e-05	0.00108	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.38e-05	0.00107	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.3e-05	0.00104	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.27e-05	0.00102	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.99e-05	0.000897	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.94e-05	0.000874	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.93e-05	0.000872	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.92e-05	0.000863	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.85e-05	0.000834	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.8e-05	0.000811	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.75e-05	0.000788	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.71e-05	0.00077	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.61e-05	0.000726	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.61e-05	0.000725	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—TP53—chronic obstructive pulmonary disease	1.6e-05	0.00072	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.59e-05	0.000716	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.54e-05	0.000696	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.54e-05	0.000695	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.48e-05	0.000665	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.45e-05	0.000652	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.44e-05	0.000647	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.4e-05	0.000631	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.38e-05	0.000624	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.38e-05	0.000621	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.34e-05	0.000605	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.32e-05	0.000597	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.26e-05	0.00057	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.23e-05	0.000556	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.23e-05	0.000552	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.21e-05	0.000548	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.19e-05	0.000537	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.17e-05	0.000527	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.16e-05	0.000525	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.14e-05	0.000516	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.11e-05	0.0005	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.06e-05	0.000476	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000471	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.71e-06	0.000438	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.58e-06	0.000432	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.53e-06	0.00043	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.26e-06	0.000418	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.92e-06	0.000402	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.78e-06	0.000396	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.46e-06	0.000381	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.44e-06	0.00038	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.34e-06	0.000376	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	7.95e-06	0.000359	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.78e-06	0.000351	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.61e-06	0.000343	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	7.61e-06	0.000343	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.33e-06	0.00033	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.23e-06	0.000326	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.73e-06	0.000303	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.51e-06	0.000294	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.44e-06	0.00029	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.38e-06	0.000288	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.87e-06	0.000265	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.85e-06	0.000264	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.77e-06	0.00026	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	5.75e-06	0.000259	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	5.5e-06	0.000248	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.41e-06	0.000244	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.37e-06	0.000242	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.1e-06	0.00023	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.51e-06	0.000203	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.45e-06	0.000201	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.34e-06	0.000196	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.15e-06	0.000187	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.15e-06	0.000187	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.93e-06	0.000177	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.46e-06	0.000156	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.31e-06	0.000149	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.67e-06	0.00012	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.56e-06	0.000115	CbGpPWpGaD
